Short C.V. Mina Tavaniotou, MD, MSc, PhD
PRELIMINARY TESTS
All couples should undergo a number of basic tests.
For woman:
- Hormonal tests (day 2-5 FSH, E2, TSH, PRL). Women over 35 or women with low number of resting follicles at ultrasound should examine their AMH
- Gynecological ultrasound to exclude any uterine or ovarian pathology
- Hysterosalpingogram days 6-12 of the cycle
- Prenatal testing:
- General blood and urine tests
- Blood type - Rhesus
- Hemoglobin electrophoresis
- Sickle cell anaemia
- Hepatitis Β, C
- HIV I and II
- Syphilis
- Toxoplasma IgG IgM
- Rubella IgG IgM
- Vaginal cultures
- Cervical cultures
- Mycoplasma
- Chlamydia
For some women laparoscopy or hysteroscopy might be indicated depending of previous history and findings of the exams
- Trial of embryo transfer
(In some cases of narrow or cervical canal, dilatation of the cervix is recommended);
For man:
- Sperm diagram and sperm culture
- Prenatal testing:
- General blood tests
- Hemoglobin electrophoresis
- Sickle cell anaemia
- Blood type - Rhesus
- HIV I and II
- Hepatitis B, C
- Syphilis
In cases of non-obstructive azoospermia or severe oligoasthenospermia, where the concentration of spermatozoa is less than 5 million/ml, the man should do:
- Testing for chromosome Y microdeletions;
- Karyotype.
In cases of obstructive azoospermia Cystic fibrosis test shoud be done
Recent Scientific Publications
Maternal menopause as a predictor of anti-Müllerian hormone level and antral follicle count in daughters during reproductive age
Is the ovarian reserve in a woman at a given age associated with her mother's age at menopause?
Read more...Should ovarian tissue freezing be considered experimental?
- Composed for IVF-Worldwide.com Blog by Dr. Sherman Silber, St Lukes Hospital, St Louis, Missouri
For fertility preservation, the ASRM has finally ruled that oocyte freezing for cancer patients, or even for social reasons is no longer to be considered experimental.
Read more...When is a pregnancy non viable?
A new article Published in journal Fertillity and Sterility in November 2012 by Tom Bourne and Cecilia Bottomley entitled “When is a pregnancy nonviable and what criteria should be used to define miscarriage” According to the article new criteria should be applied to avoid considering as miscarriages pregnancies that are otherwise viable.
Read more...A new prenatal test for early non invasive detection of Down’s syndrome
Blood test introduced in german-speaking countries might reduce the number of amniocentesis for detection of Downs’ syndrome
Read more...Publications abstracts in peer reviewed journals
-
Cecal volvulus after twin gestation: laparoscopic approach
-
Comparison between different routes of progesterone administration as luteal phase support in infertility treatments
-
Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
-
Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist.
-
Endometrial hormone receptors and proliferation index on the day of ovum pick-up in GnRH analogue/hMG stimulated cycles with embryo transfer. Comparison to natural cycles and relation to clinical pregnancies
-
Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization.
-
GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial
-
Impact of ovarian stimulation on corpus luteum function and embryonic implantation
-
Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients
-
Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
-
Ovulation induction disrupts luteal phase function.
-
The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate / gonadotrophin / 0.25 mg cetrorelix